Abstract
Objective: The purpose of this study was to compare the clinical efficacy and safety of intravenous trospectomycin to that of cefoxitin plus doxycycline in the treatment of women hospitalized with acute pelvic inflammatory disease (PID).
Methods: Thirty-nine patients admitted with a clinical diagnosis of an acute PID were enrolled in this prospective, single-blind study. Patients were treated with either intravenous trospectomycin, 500 mg every 8 h, or intravenous cefoxitin, 2 g every 6 h, plus oral or intravenous doxycycline, 100 mg every 12 h, in a 2:1 ratio. The patients were followed for clinical response and side effects. Both groups of patients were discharged on oral doxycycline for 10 days. Appropriate cultures were obtained before starting inpatient treatment, on completion of inpatient treatment, and at 2 follow-up visits.
Results: The overall success rate for trospectomycin was 95.6% and for cefoxitin/doxycycline was 91.6%. This difference was not statistically significant (P = 0.63). Trospectomycin was found to be effective against Chlamydia trachomatis.
Conclusions: Single-agent therapy with trospectomycin may be as effective as cefoxitin plus doxycycline in the treatment of women hospitalized with acute PID.
Full Text
The Full Text of this article is available as a PDF (336.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brunham R. C., Binns B., Guijon F., Danforth D., Kosseim M. L., Rand F., McDowell J., Rayner E. Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis. 1988 Sep;158(3):510–517. doi: 10.1093/infdis/158.3.510. [DOI] [PubMed] [Google Scholar]
- Echániz Avilés G., Conde González C., Juárez Figueroa L., Carnalla Barajas N., Tamayo Legorreta E., Calderón Jaimes E. In vitro activity of several antimicrobial agents against genital mycoplasmas. Clin Ther. 1992 Sep-Oct;14(5):688–695. [PubMed] [Google Scholar]
- Eschenbach D. A., Buchanan T. M., Pollock H. M., Forsyth P. S., Alexander E. R., Lin J. S., Wang S. P., Wentworth B. B., MacCormack W. M., Holmes K. K. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med. 1975 Jul 24;293(4):166–171. doi: 10.1056/NEJM197507242930403. [DOI] [PubMed] [Google Scholar]
- Hager W. D., McDaniel P. S. Treatment of serious obstetric and gynecologic infections with cefoxitin. J Reprod Med. 1983 May;28(5):337–340. [PubMed] [Google Scholar]
- Kuo C. C., Grayston J. T. In vitro drug susceptibility of Chlamydia sp. strain TWAR. Antimicrob Agents Chemother. 1988 Feb;32(2):257–258. doi: 10.1128/aac.32.2.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martinusen S., Chen D., Frighetto L., Bunz D., Stiver H. G., Jewesson P. J. Comparison of cefoxitin and ceftizoxime in a hospital therapeutic interchange program. CMAJ. 1993 Apr 1;148(7):1161–1169. [PMC free article] [PubMed] [Google Scholar]
- Mroczkowski T. F., Millikan L. E., Martin D. H., Leonik K. J. Treatment of gonococcal infections with a single 250 mg intramuscular injection of trospectomycin sulphate vs ceftriaxone sodium. Drugs Exp Clin Res. 1993;19(1):41–46. [PubMed] [Google Scholar]
- Nichols D. J., Bye A., Novak E. Pharmacokinetics of trospectomycin sulphate in healthy subjects after single intravenous and intramuscular doses. Br J Clin Pharmacol. 1991 Aug;32(2):255–257. doi: 10.1111/j.1365-2125.1991.tb03893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paavonen J., Teisala K., Heinonen P. K., Aine R., Laine S., Lehtinen M., Miettinen A., Punnonen R., Grönroos P. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol. 1987 May;94(5):454–460. doi: 10.1111/j.1471-0528.1987.tb03125.x. [DOI] [PubMed] [Google Scholar]
- Soper D. E., Brockwell N. J., Dalton H. P., Johnson D. Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol. 1994 Apr;170(4):1008–1017. doi: 10.1016/s0002-9378(94)70094-x. [DOI] [PubMed] [Google Scholar]
- Wright D. B. Antimicrobial formulary management: a case study in a teaching hospital. Pharmacotherapy. 1991;11(1 ):27S–31S. [PubMed] [Google Scholar]
- Yagi B. H., Schaadt R. D., Zurenko G. E. The bactericidal activity and postantibiotic effect of trospectomycin. Diagn Microbiol Infect Dis. 1992 Jul;15(5):417–423. doi: 10.1016/0732-8893(92)90083-6. [DOI] [PubMed] [Google Scholar]
- Zurenko G. E., Yagi B. H., Vavra J. J., Wentworth B. B. In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog. Antimicrob Agents Chemother. 1988 Feb;32(2):216–223. doi: 10.1128/aac.32.2.216. [DOI] [PMC free article] [PubMed] [Google Scholar]